Ferguson joins lawsuit against Novartis Pharmaceuticals Corporation in alleged kick-back scheme
OLYMPIA—Attorney General Bob Ferguson today filed a motion to intervene in a civil lawsuit against Novartis Pharmaceuticals Corporation.
The suit alleges Novartis paid kickbacks to BioScrip, Inc., a pharmacy headquartered in New York, to boost sales of Novartis’ drug, Exjade. Exjade was approved by the Food and Drug Administration in late 2005 for the treatment of chronic iron overload due to blood transfusions.
Other Languages